Impact of rivastigmine use on the risk of nursing home placement in a US sample

Although numerous studies have evaluated predictors of nursing home placement (NHP), few have focused on the effects of cholinesterase inhibitor (ChEI) use on NHP. The objective of this study was to compare the risk of NHP between rivastigmine patients versus no-ChEI patients (control group), and se...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS drugs 2004-01, Vol.18 (15), p.1143-1148
Hauptverfasser:	BEUSTERIEN, Kathleen M, THOMAS, Simu K, GAUSE, Douglas, KIMEL, Miriam, ARCONA, Stephen, MIRSKI, Dario
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Alzheimer Disease - drug therapy Biological and medical sciences Cholinesterase Inhibitors - administration & dosage Cholinesterase Inhibitors - therapeutic use Cohort Studies Databases, Factual - statistics & numerical data Drug Utilization Review Female Humans Indans - administration & dosage Indans - therapeutic use Insurance Male Medical sciences Neuropharmacology Nursing Homes Pharmacology. Drug treatments Phenylcarbamates - administration & dosage Phenylcarbamates - therapeutic use Piperidines - administration & dosage Piperidines - therapeutic use Proportional Hazards Models Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Retrospective Studies Risk Assessment Rivastigmine Time Factors United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!